RE: From Markus other board interesting /how-tesaro-got-its-5-1-billion-glaxosmithkline-buyout7 Jun 2022 08:38
Dostarlimab, a monoclonal antibody drug, smashed expectations in a recent trial run by Memorial Sloan Kettering Cancer Center in New York, sponsored by pharmaceutical giant GlaxoSmithKline (GSK).